子宫内膜异位症和不良怀孕结果:全国性基于人口的研究
Hee Jeung Lim1,2, Jiyu Sun3, Banhyang Min1,2
1Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Journal of clinical medicine
|August 26, 2023
概括
患有子宫内膜异位症的妇女面临更高风险的不良妊娠结果,包括早产,子宫前和出血,即使在成功怀孕后. 这种情况在怀孕期间会影响生育能力和母亲的健康.
科学领域:
- 生殖医学 生殖医学
- 产科和妇科 产科和妇科
- 临床流行病学临床流行病学
背景情况:
- 子宫内膜异位症是导致不孕症的一个重要因素.
- 其已知的病理生理学表明,它可能对怀孕结果产生不良影响.
- 以前的研究表明子宫内膜异位症与受孕困难之间存在联系.
研究的目的:
- 调查子宫内膜异位症和成功受孕后不良妊娠结果之间的关联.
- 为了比较怀孕后果在女性和没有子宫内膜异位症.
- 为了确定与妊娠期间子宫内膜异位症相关的特定风险和并发症.
主要方法:
- 使用来自韩国医疗保险审查和评估服务数据库的数据进行回顾性队列研究.
- 在2014年1月至2019年10月期间,对单独妊娠分娩的分析.
- 在子宫内膜异位症和非子宫内膜异位症组之间比较临床特征和不良妊娠结果.
主要成果:
- 患有子宫内膜异位症的妇女 (2.6%的队列) 经历了明显更不利的妊娠结果.
- 相关结果包括早产,孕前,胎儿生长限制,胎盘并发症,出血和死产.
- 在子宫内膜异位症组中观察到产后出血,输血,子宫动脉栓塞,剖腹产切除以及剖腹产分娩率较高的风险增加.
结论:
- 子宫内膜异位症与出现不良妊娠结果的风险大大增加有关.
- 这些发现强调了子宫内膜异位症对生育能力和母胎健康的双重影响.
- 患有子宫内膜异位症的妇女需要在整个怀孕期间进行仔细监测,因为并发症风险较高.
更多相关视频
07:20Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity
Published on: December 21, 2012
16.0K
11:29Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
Published on: January 22, 2022
14.3K
相关概念视频
02:07Oogenesis
63.8K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.8K
01:27Ovarian Cycle
1.4K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.4K
01:07Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K